AbstractTwo DNA constructs encoding portions of the human immunodeficiency virus type-1 (HIV-1) genome have been used to raise antibody responses in BABL/c mice. One DNA (pNL4-3.env) expresses the natural form of the envelope glycoprotein (Env) of HIV-1-NL4-3 (NL4-3). The second (pNL4-3.dpol) produces noninfectious NL4-3 particles. These two DNAs (alone or in combination) raised only transient titers of anti-Env IgG. In the same group in which pNL4-3.dpol DNA raised only transient antibody responses to Env, this DNA raised persistent antibody responses to the p24 virion capsid protein (CA). Antibody responses to Env and CA also showed different abilities to be boosted. The final boosts of pNL4-3.dpol DNA increased titers of anti-CA antibody...
BACKGROUND: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize...
DNA vaccines based on subunits from pathogens have several advantages over other vaccine strategies....
The importance of a balanced TH1/TH2 humoral immune response against the HIV-1 envelope protein (Env...
AbstractTwo DNA constructs encoding portions of the human immunodeficiency virus type-1 (HIV-1) geno...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly ...
DNA vaccination can elicit both humoral and cellular immune responses and can confer protection agai...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly ...
Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is ...
Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is ...
DNA vaccination can elicit both humoral and cellular immune responses and can confer protection agai...
As part of a European initiative (EuroVacc), we report the design, construction, and immunogenicity ...
BACKGROUND: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize...
BACKGROUND: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize...
DNA vaccines based on subunits from pathogens have several advantages over other vaccine strategies....
The importance of a balanced TH1/TH2 humoral immune response against the HIV-1 envelope protein (Env...
AbstractTwo DNA constructs encoding portions of the human immunodeficiency virus type-1 (HIV-1) geno...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly ...
DNA vaccination can elicit both humoral and cellular immune responses and can confer protection agai...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
An effective HIV vaccine will most likely require the induction of strong T-cell responses, broadly ...
Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is ...
Heterologous prime boost with DNA and recombinant modified vaccinia virus Ankara (rMVA) vaccines is ...
DNA vaccination can elicit both humoral and cellular immune responses and can confer protection agai...
As part of a European initiative (EuroVacc), we report the design, construction, and immunogenicity ...
BACKGROUND: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize...
BACKGROUND: In order to develop a more effective prophylactic HIV-1 vaccine it is important optimize...
DNA vaccines based on subunits from pathogens have several advantages over other vaccine strategies....
The importance of a balanced TH1/TH2 humoral immune response against the HIV-1 envelope protein (Env...